KEY TAKEAWAY: According to the World Health Organization (WHO), the number of people living with diabetes has quadrupled since 1980, growing to more than 400 million. And with this rise in disease, sales of diabetes-related products have also climbed. In fact, in 2015, American consumers spent $592 million on such products.The cost of diabetes drugs rose 150 percent for six popular, brand-name diabetes drugs in the past five years. Two of these drugs rose in price more than 250 percent. Continue reading “Diabetes drug costs”
KEY TAKEAWAY: Digital health is getting bigger every day, but when patients rely on digital health instead of seeing a health care professional it could lead to more serious conditions and higher health costs. Digital health should empower patients, but it isn’t a replacement for good, sound, medical consultations. Continue reading “Why doctors should be concerned about digital health”
KEY THOUGHT: While the AMA points the finger at pharma for DTC ads most doctors are failing patients by not warning them of the dangers of obesity and unhealthy lifestyles. Continue reading “How some doctors are failing patients”
KEY TAKEAWAY: Insurers are having a bigger say in what physicians prescribe to patients and it seems that many are telling patients to check with their insurance companies before writing a new Rx. Pharma marketers need to be aware of this trend and provide information to patients to help them determine if a product will be covered BEFORE they request it. Continue reading “The big change in the way doctors prescribe medications”
KEY TAKEAWAY: As drugs for many common conditions lose patent protection and face generic competition, branded drug companies increasingly are relying on revenue from drugs for serious and sometimes rare conditions, a class of medicines known as “specialty drugs.” However, these specialty drugs can cost tens of thousands of dollars but in an era of “healthcare consumerism” DTC ads are not going to help overcome sticker shock.